| PERIOD ENDING | 31-Mar-08 | | Total Revenue | 19,155 | | Cost of Revenue | 7,549 | | | Gross Profit | 11,606 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 714 | | Non Recurring |
-
| | Others |
-
| | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 10,892 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 276 | | Earnings Before Interest And Taxes | 11,168 | | Interest Expense |
-
| | Income Before Tax | 11,168 | | Income Tax Expense | 1,845 | | Minority Interest |
-
| | | | Net Income From Continuing Ops | 9,323 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 9,323 | | Preferred Stock And Other Adjustments | (1,633) | | | Net Income Applicable To Common Shares | $7,690 |
|
0.11% Nasdaq 
0.01%
Income Statement
